Takagi Tadataka, Koyama Fumikazu, Kuge Hiroyuki, Iwasa Yosuke, Takei Takeshi, Sadamitsu Tomomi, Fujimoto Kosuke, Harada Suzuka, Tamura Takashi, Ejiri Goki, Yoshikawa Chihiro, Sho Masayuki
Department of Surgery, Nara Medical University, Kashihara, Japan.
Division of Endoscopy, Nara Medical University, Kashihara, Japan.
J Anus Rectum Colon. 2024 Jul 30;8(3):188-194. doi: 10.23922/jarc.2023-034. eCollection 2024.
This study aimed to investigate the impact of the COVID-19 pandemic on the examination and treatment of colorectal cancer (CRC) and on the behaviors of patients and practitioners.
This is a retrospective analysis of the CRC patients who presented to our department between April 2019 and March 2021 and underwent surgery. Clinical presentation of CRC and time from symptom onset to medical presentation were compared between the control (April 2019 to March 2020, n=124) and COVID-19 pandemic periods (April 2020 to March 2021, n=111).
Two hundred and thirty-five patients were reviewed. The rate of positive fecal occult blood tests was significantly lower during the COVID-19 pandemic period (13.5 vs. 25.0%, = 0.027). Among the symptomatic patients who had melena and abdominal symptoms, the time from symptom onset to medical presentation was significantly longer during the COVID-19 period (115 vs. 31 days, < 0.001). In addition, the interval between presenting to a practitioner and being referred to our department was similar between the two periods (19 vs. 13 days, = 0.092). There were no significant differences in the stage of cancer between the two periods. The rate of preoperative sub-obstruction was significantly higher during the COVID-19 period (41.4 vs 23.4%, = 0.003). There was no significant difference in overall survival and recurrence-free survival between two periods.
Hesitation to seek examination and treatment for CRC was observed in patients but not in practitioners during the COVID-19 pandemic period. The prognosis did not change.
本研究旨在调查2019冠状病毒病(COVID-19)大流行对结直肠癌(CRC)检查和治疗以及患者和从业者行为的影响。
这是一项对2019年4月至2021年3月期间到我院就诊并接受手术的CRC患者的回顾性分析。比较了对照组(2019年4月至2020年3月,n = 124)和COVID-19大流行期间(2020年4月至2021年3月,n = 111)CRC的临床表现以及从症状出现到就医的时间。
共纳入235例患者。COVID-19大流行期间粪便潜血试验阳性率显著降低(13.5%对25.0%,P = 0.027)。在有黑便和腹部症状的有症状患者中,COVID-19期间从症状出现到就医的时间显著更长(115天对31天,P < 0.001)。此外,两个时期从就诊于从业者到转诊至我院的间隔相似(19天对13天,P = 0.092)。两个时期癌症分期无显著差异。COVID-19期间术前亚梗阻发生率显著更高(41.4%对23.4%,P = 0.003)。两个时期总生存率和无复发生存率无显著差异。
在COVID-19大流行期间,观察到患者对CRC检查和治疗存在犹豫,但从业者没有。预后没有改变。